AAV-MECP2

AAV-MECP2 gene therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AAV-MECP2, covering 2025-07-01 to 2025-07-01. Get the full timeline:

Most recent: Clinical Trial Update: Single-Dose AAV-MECP2 Safety/Tolerability and Efficacy in Rett Syndrome [EARLY_Phase 1]